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TECHNICAL NOTE
Quantitative assessment of procoagulant activity
in isolated rat glomeruli
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with the technical assistance of VÉRONIQUE LE FLOCH
Laboratoire d'Immunologie et d'Hema:ologie, Université Paris 7, C.H. U. Bichat and Service de Nephrologie,
C.H. U. Bichat, Paris, France
Tissue extracts from kidney of humans and other mammali-
ans contain a procoagulant activity (PCA) that has been iden-
tified as tissue factor-like (TF) [1—3]. This activity appears to be
located mainly in the renal cortex. To our knowledge, however,
TF activity specifically bound to glomerular structures has not
been demonstrated. The assay system described herein pro-
vides evidence of such an activity in glomeruli isolated from rat
and allows its quantitative measurement. We suggest that this
technique could be useful to investigate further the mechanisms
of deposition of fibrin as observed in several types of experi-
mental glomerulonephritides (GN),
Methods
Male Sprague-Dawley rats, weighing 170 to 230 g and anes-
thetized with ether, were used in all experiments.
Isolation of glomeruli
Following abdominal incision, the kidneys were washed until
blanched with heparinized isotonic saline via a cannula inserted
in the lower aorta. Isolated glomeruli were obtained according
to a previously described method with minor modifications [41;
in brief, the minced cortex of the kidneys was pushed through
a 106 s-sieve and the glomeruli were washed twice and resus-
pended in phosphate buffered saline (PBS; 0.13 M NaCl, 0,005
M Na2HPO4, 0.0015 M KH2PO4, pH 7.2). Purity of the suspen-
sions were checked microscopically. The suspensions con-
tained 1 to 20 x i03 glomeruli per ml, determined by phase-
contrast microscopy. The glomerular suspensions were used
immediately after their preparation (intact glomeruli) or kept
frozen at —80°C. The latter were either used immediately after
being thawed or disrupted mechanically with the Lox-Press
system (Biox, Sweden) before performing clotting assays; that
all the glomeruli were disrupted was controlled optically.
Clotting assays
The coagulation tests were performed with citrated rat
plasma as substate. To prepare rat platelet-poor plasma (PPP),
blood (1.6 ml) was drawn by puncturing the abdominal aorta
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and was collected in 0.4 ml of 0.13 M trisodic citrate according
to Lyberg, Hetland, and Prydz [5] to avoid activation of
coagulation in most samples. The blood was centrifuged at
3000g for 15 mm at 4°C. The plasma samples were screened for
activation of coagulation, and all samples with a recalcification
time of less than 100 sec were discarded. The plasmas were
pooled and stored by aliquots at —80°C. The recalcification time
of PPP was used to assess the PCA of the glomeruli as follows:
100 d of 30 mri CaC12 was added to 100 pi PPP mixed with 100
1.d of the test suspension and the clotting time recorded.
Clotting times were compared to a standard curve generated
using rat brain thromboplastin [61. This standard preparation
was taken arbitrarily to contain 1,000 TF units/mi. Dilutions
were used to establish the calibration curve, which was linear
on a bilogarithmic plot (r = 0.99, slope 0.25). The mean
results 1 sr obtained with five different batches of PPP were:
1,000 U/mi: 20.2 0.6 sec (N = 22); 500 U/mI: 23.4 0.5 sec
(N = 18); 250 U/mI: 27.3 1.1 sec (N = 22); 125 U/ml: 34.4
0.6 sec (N = 6); 62.5 U/mI: 39.6 3.5 sec (N = 22). When the
clotting time of the test suspension was shorter than 20 sec, the
suspension was diluted in PBS. In some experiments, human
plasma deficient in factor VII, VIII or X (obtained from Dade
Laboratories, Aguada, Puerto Rico) was used instead of rat PPP
in order to characterize PCA. In these experiments, the clotting
time of normal human PPP mixed with rat thromboplastin was
used as a control to verify that species specificity of PCA did
not interfere with the results. To further characterize PCA, the
effects of diisopropyifluorophosphate (DFP) and phospholipase
C (PLC) were assessed. DFP (Sigma Chemical Co., St. Louis,
Missouri, USA) at a final concentration of 2 m was incubated
30 mm with the glomerular suspension at 22°C; after centrifu-
gation, the DFP-containing supernatant was discarded and
replaced by fresh PBS just before the recalcification time was
recorded. PLC (Sigma type III from Bacillus cereus) at a final
concentration of 5 tg/ml was incubated 15 mm at 37°C with the
glomerular suspension, and the recalcification time was tested
as described.
The protein concentration of glomerular suspensions was
measured according to Lowry et al. [7] using bovine serum
albumin (Pentex Miles, Elkhart, Indiana, USA) as a standard.
Differences between the TF units exhibited by intact, frozen-
thawed, and Lox-Press treated glomerular suspensions were
assessed statistically by the Student's t test.
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Table 1. Characterization of glomerular PCA
Clotting time, sec







PBS 150 190 > 300 176 > 300
Thromboplastin (1:4 in PBS) 26.1 66.4 75 145 > 300
Glomerular suspension, 600 Ixg giom. protein/mi 36.8 72 74 164 > 300
The recalcification clotting ime of normal and deficient plasmas was determined as described in the text for each sample.
Glomerular
TF units/mg of gb merular protein
Control Treated Residual PCA in %
suspension (PBS) with PLC of initial value
1 824 19 2.3
2 730 6 <1
3 625 2 <1
4 411 3 <1
Results
Evidence and characteristics of PCA
Glomerular suspensions invariably shortened the recalcifica-
tion time of PPP. A typical intact glomerular suspension (pro-
tein content 965 g/ml) shortened the clotting time from 140 (for
the control) to 35 sec. After Lox-Press disruption, the clotting
time was 18.6 sec; serial dilutions of this disrupted glomerular
suspension exhibited the following clotting times: 1:2 = 21.6
sec; 1:4 = 25 sec; 1:8 = 30.6 sec; 1:16 = 36.6 sec. The log-log
plot yielded a straight line (r = 0.99) with a slope (0.26) identical
to that obtained with serial dilutions of brain thromboplastin
(0.25); this allowed us to compare different samples in terms of
quantities.
The effect of suspended glomeruli was compared to that of rat
brain thromboplastin, not only on rat PPP, but also on normal
human PPP and human plasma deficient in factor VII or VIII.
Rat thromboplastin and suspended glomeruli had no effect on
the recalcification time of human plasmas deficient in either
factor VII or factor X; in contrast, both shortened the clotting
time of rat PPP, normal human plasma, and human plasma
deficient in factor VIII. The results of a typical experiment are
shown in Table 1. Incubation with DFP did not change the PCA
of the glomerular suspensions (4 experiments), while incubation
with PLC completely inhibited PCA, as shown in Table 2.
Quantification of rat glomerular PCA
Results are shown in Figure 1. In suspensions of intact
glomeruli, the mean TF units SE were 0.185 0.030 per g of
glomerular protein; in suspensions of frozen-thawed glomeruli
this value was about twofold higher: 0.411 0.035 per g of
glomerular protein. Suspensions of mechanically disrupted
glomeruli exhibited a still higher PCA, about six times that of
intact glomeruli: 1.18 0.11 TF units per tg of glomerular






Fig. 1. Tissue-factor units per g giomerular protein of intact • (N =
13), frozen-thawed (N = 36) and mechanically disrupted 0 (N = 15)
glomeruli. * P < 0.001 vs. frozen-thawed glomeruli *P < 0.001 vs.
intact glomeruli.
PCA and the protein content (130 to 1820 p.g/ml) of suspensions
of glomeruli that were either intact (P < 0.02, N = 13),
frozen-thawed (P < 0.001, N = 36), or disrupted (P < 0.05, N
= 15). This shows that TF activity can be measured reliably
over this range of protein concentration.
Table 2. Inactivation by phospholipase C (PLC) of the procoagulant
activity of rat glomeruli
1.2
1.0—
PCA of the gbomerular suspensions was measured after incubation
with PLC for 15 mm at 37°C (details in text).
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Discussion
The present work shows that isolated rat glomeruli contain a
PCA that exhibits the well-established characteristics of
thromboplastin (tissue factor): specifically, activity depends on
the presence of factors VII and X; activity is retained after
incubation with DFP, an inhibitor of serine proteases, notably
factor Xa [81; and activity is suppressed by PLC, an inhibitor of
the phospholipid component of tissue factor [9]. These findings
confirm the data obtained by Astrup who demonstrated the
presence of thromboplastin in the rat kidney [1]; our results also
indicate that this activity is, at least in part, located in the
glomeruli. A significant positive correlation was found between
TF activity and the protein concentration of glomerular suspen-
sions. We thus suggest that this method could be used for the
accurate assessment of glomerular PCA under various condi-
tions, notably in investigating the detailed mechanisms of fibrin
deposition in experimental GN.
This study has also shown that glomerular TF activity is
largely latent, as its expression increases severalfold with
cellular trauma produced by freezing or mechanical disruption.
This observation is consistent with previous observations that
show an enhancement of approximately two- to tenfold in the
TF activity of various types of cultured cells (including
endothelial cells) after disruption [10—12]. Furthermore, this
observation emphasizes the importance of evaluating the cell
surface available PCA expressed by intact glomeruli and the
total glomerular PCA which, as we have shown, is better
recovered after Lox-Press treatment than after freezing and
thawing.
In conclusion, our results demonstrate that PCA is present in
isolated glomeruli. PCA, which has been described as tissue
factor-like, is mainly intracellular. The described methodologi-
cal approach might be used in further studies designed to
establish, first, the type or types of glomerular cells producing
this activity and, second, whether glomerular PCA could be
related to the fibrin deposition that occurs in certain types of
glomerulonephritides.
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